NO994995D0 - Fremgangsmåte for identifisering av forbindelser for inhibering av neoplastiske lesjoner og farmasöytiske blandinger inneholdende slike forbindelser - Google Patents
Fremgangsmåte for identifisering av forbindelser for inhibering av neoplastiske lesjoner og farmasöytiske blandinger inneholdende slike forbindelserInfo
- Publication number
- NO994995D0 NO994995D0 NO994995A NO994995A NO994995D0 NO 994995 D0 NO994995 D0 NO 994995D0 NO 994995 A NO994995 A NO 994995A NO 994995 A NO994995 A NO 994995A NO 994995 D0 NO994995 D0 NO 994995D0
- Authority
- NO
- Norway
- Prior art keywords
- compound
- compounds
- activity
- determining
- pde
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/173,375 US6200771B1 (en) | 1998-10-15 | 1998-10-15 | Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia |
| US09/366,003 US6130053A (en) | 1999-08-03 | 1999-08-03 | Method for selecting compounds for inhibition of neoplastic lesions |
| US09/414,628 US20020009764A1 (en) | 1999-10-08 | 1999-10-08 | Methods for identifying compounds for inhibition of neoplastic lesions, and pharmaceutical compositions containing such compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO994995D0 true NO994995D0 (no) | 1999-10-14 |
| NO994995L NO994995L (no) | 2000-04-17 |
Family
ID=27390268
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO994995A NO994995L (no) | 1998-10-15 | 1999-10-14 | FremgangsmÕte for identifisering av forbindelser for inhibering av neoplastiske lesjoner og farmasøytiske blandinger inneholdende slike forbindelser |
| NO20062682A NO20062682L (no) | 1998-10-15 | 2006-06-09 | Farmasoytiske blandinger inneholdende forbindelser for inhibering av neoplastiske lesjoner |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20062682A NO20062682L (no) | 1998-10-15 | 2006-06-09 | Farmasoytiske blandinger inneholdende forbindelser for inhibering av neoplastiske lesjoner |
Country Status (13)
| Country | Link |
|---|---|
| EP (2) | EP0997145B1 (no) |
| JP (1) | JP2000186047A (no) |
| CN (1) | CN100389829C (no) |
| AT (1) | ATE214920T1 (no) |
| AU (1) | AU770308B2 (no) |
| CA (1) | CA2284853A1 (no) |
| DE (1) | DE69901082T2 (no) |
| DK (1) | DK0997145T3 (no) |
| ES (1) | ES2174573T3 (no) |
| IL (1) | IL132366A0 (no) |
| NO (2) | NO994995L (no) |
| TR (1) | TR199902578A3 (no) |
| TW (1) | TWI239837B (no) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002531826A (ja) * | 1998-11-25 | 2002-09-24 | セル パスウェイズ インコーポレイテッド | 新形成診断法 |
| US6569638B1 (en) * | 2000-03-03 | 2003-05-27 | Cell Pathways, Inc | Method for screening compounds for the treatment of neoplasia |
| CZ2003486A3 (cs) * | 2000-08-21 | 2003-05-14 | Astrazeneca Ab | Chinazolinové deriváty, způsob jejich přípravy a farmaceutický prostředek, který je obsahuje |
| WO2004044234A1 (en) * | 2002-11-13 | 2004-05-27 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 2a (pde2a) |
| JP4641942B2 (ja) | 2003-10-03 | 2011-03-02 | フェーイレン・ナムローゼ・フェンノートシャップ | ヒトおよび動物におけるｉｇｆ−１血清レベルの低下と関連した種々の疾患状態の治療用の治療用組成物の製造のための血清中ｉｇｆ−１レベルを増加できる化合物の使用 |
| WO2005054181A1 (ja) * | 2003-12-01 | 2005-06-16 | Reverse Proteomics Research Institute Co., Ltd. | 抗癌剤の新規標的タンパク質および対応する新規抗癌剤（スプナール） |
| JP5219135B2 (ja) * | 2008-07-25 | 2013-06-26 | 独立行政法人産業技術総合研究所 | 炎症性疾患モデル動物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0508586B1 (en) * | 1991-03-08 | 1995-05-31 | Fgn, Inc. | Substituted indenyl compounds |
| US5696159A (en) * | 1994-08-03 | 1997-12-09 | Cell Pathways, Inc. | Lactone compounds for treating patients with precancerous lesions |
| US5776962A (en) * | 1994-08-03 | 1998-07-07 | Cell Pathways, Inc. | Lactone compounds for treating patient with precancerous lesions |
| US5998477A (en) * | 1996-06-13 | 1999-12-07 | Cell Pathways Inc. | Substituted methoxy benzylidene indenyl-acetic and propionic acids for treating patients with precancerous lesions |
| US6063818A (en) * | 1996-06-13 | 2000-05-16 | Cell Pathways Inc. | Substituted benzylidene indenyl formamides, acetamides and propionamides |
| AU740783B2 (en) * | 1996-09-18 | 2001-11-15 | Applied Genetics Incorporated Dermatics | Pharmaceutical compositions and methods |
| CA2238283C (en) * | 1997-05-30 | 2002-08-20 | Cell Pathways, Inc. | Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions |
| US5922595A (en) * | 1997-12-09 | 1999-07-13 | Incyte Pharmaceuticals, Inc. | Cyclic GMP phosphodiesterase |
| JP4307719B2 (ja) * | 1997-12-12 | 2009-08-05 | セル パスウェイズ インコーポレイテッド | 新形成治療用のｎ−ベンジル−３−インデニルアセトアミド誘導体 |
-
1999
- 1999-10-13 IL IL13236699A patent/IL132366A0/xx not_active IP Right Cessation
- 1999-10-14 CA CA002284853A patent/CA2284853A1/en not_active Abandoned
- 1999-10-14 DE DE69901082T patent/DE69901082T2/de not_active Expired - Fee Related
- 1999-10-14 EP EP99308129A patent/EP0997145B1/en not_active Expired - Lifetime
- 1999-10-14 AU AU54010/99A patent/AU770308B2/en not_active Ceased
- 1999-10-14 TW TW088117817A patent/TWI239837B/zh active
- 1999-10-14 EP EP01119687A patent/EP1161943A3/en not_active Withdrawn
- 1999-10-14 AT AT99308129T patent/ATE214920T1/de not_active IP Right Cessation
- 1999-10-14 ES ES99308129T patent/ES2174573T3/es not_active Expired - Lifetime
- 1999-10-14 DK DK99308129T patent/DK0997145T3/da active
- 1999-10-14 NO NO994995A patent/NO994995L/no not_active Application Discontinuation
- 1999-10-15 JP JP11330364A patent/JP2000186047A/ja active Pending
- 1999-10-15 CN CNB991218183A patent/CN100389829C/zh not_active Expired - Fee Related
- 1999-10-15 TR TR1999/02578A patent/TR199902578A3/tr unknown
-
2006
- 2006-06-09 NO NO20062682A patent/NO20062682L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2284853A1 (en) | 2000-04-15 |
| DK0997145T3 (da) | 2002-07-29 |
| JP2000186047A (ja) | 2000-07-04 |
| CN100389829C (zh) | 2008-05-28 |
| TWI239837B (en) | 2005-09-21 |
| ES2174573T3 (es) | 2002-11-01 |
| CN1255379A (zh) | 2000-06-07 |
| AU770308B2 (en) | 2004-02-19 |
| EP1161943A3 (en) | 2003-12-10 |
| DE69901082T2 (de) | 2002-08-29 |
| NO994995L (no) | 2000-04-17 |
| IL132366A0 (en) | 2001-03-19 |
| EP0997145B1 (en) | 2002-03-27 |
| TR199902578A2 (xx) | 2000-06-21 |
| NO20062682L (no) | 2000-04-17 |
| ATE214920T1 (de) | 2002-04-15 |
| EP1161943A2 (en) | 2001-12-12 |
| AU5401099A (en) | 2000-04-20 |
| DE69901082D1 (de) | 2002-05-02 |
| TR199902578A3 (tr) | 2000-06-21 |
| EP0997145A1 (en) | 2000-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20062682L (no) | Farmasoytiske blandinger inneholdende forbindelser for inhibering av neoplastiske lesjoner | |
| ATE307119T1 (de) | Bicyclische protein-farnesyl-transferase inhibitoren | |
| TR199802136T2 (xx) | �MPDH enzimi inhibit�rleri olarak �re t�revleri. | |
| NO965524D0 (no) | Tri-substituerte fenylderivater anvendelige som PDE IV inhibitorer | |
| AP1498A (en) | Inhibitors of impdh enzyme. | |
| TR199901191T2 (xx) | Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�. | |
| UA83243C2 (ru) | Соединения, которые ингибируют натриезависимый переносчик глюкозы | |
| NO996578L (no) | Urokinase-inhibitorer | |
| YU76401A (sh) | 1-amino triazolo(4,3-a)hinazolin-5-oni i/ili - 5-tioni koji inhibiraju fosfodiesteraze iv | |
| NO20003018D0 (no) | Triazinangiogenese-inhibitorer | |
| BR0211118A (pt) | Composto, métodos para o tratamento ou prevenção de doenças e para fabricar um composto, intermediário, e, uso de um composto ou sal | |
| CA2238283A1 (en) | Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions | |
| DE69911935D1 (de) | Granulatimide-derivate zur behandlung von krebs | |
| MXPA03011466A (es) | Macrociclos utiles en tratamiento de enfermedades de alzheimer. | |
| ATE326964T1 (de) | Aminosäurederivate zur behandlung der alzheimer- krankheit | |
| MA27257A1 (fr) | Composes utiles pour le traitement du charbon et l'inhibition du gene letal | |
| CY2225B1 (en) | Organic compounds | |
| NO308829B1 (no) | Anvendelse av forbindelsen finasterid for fremstilling av et preparat for behandling av kronisk prostatitt hos menn | |
| MXPA03011399A (es) | Metodos para tratar la enfermedad de alzheimer. | |
| SI1077694T1 (en) | Aryl nitrone therapeutics for the treatment of inflammatory bowel disease | |
| ES2185154T3 (es) | Metodo de uso de inhibidores de la ciclooxigenasa-2 en el tratamiento y prevencion de la demencia. | |
| ECSP982536A (es) | Compuestos utiles para la inhibicion de transferasa de proteina al farnesilo ( case ino750k) | |
| ES2114476A1 (es) | Nuevas penicilinas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |